Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2011)Shigeru Nakai, Yoshiharu Tsubakihara, Yuzo Watanabe et al.|Therapeutic Apheresis and Dialysis|2013Cited by 198
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortalityKosaku Nitta, Terumasa Hayashi, Shunsuke Goto et al.|Renal Replacement Therapy|2020Cited by 170
Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patientsJunichiro James Kazama, Masafumi Fukagawa, Fuminori Sato et al.|Kidney International|2005Cited by 132
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)Shigeru Nakai, Yoshiharu Tsubakihara, Kunitoshi Iseki et al.|Therapeutic Apheresis and Dialysis|2012Cited by 129
An Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2012)Shigeru Nakai, Yoshiharu Tsubakihara, Norio Hanafusa et al.|Therapeutic Apheresis and Dialysis|2014Cited by 121